Nagele Peter, Zorumski Charles F, Conway Charles
J Clin Psychopharmacol. 2018 Apr;38(2):144-148. doi: 10.1097/JCP.0000000000000837.
Nitrous oxide (laughing gas) has shown early promise as a rapidly acting antidepressant in patients with treatment-resistant major depression and is currently investigated in several clinical trials. Because nitrous oxide is rarely administered outside operating rooms or dental practices, most psychiatrists are not familiar with how nitrous oxide is administered in a medical setting and what regulations guide its use. The goal of this brief review was to educate psychiatrists about the basic concepts of nitrous oxide administration and pharmacology. Furthermore, common misconceptions about nitrous oxide will be discussed.
一氧化二氮(笑气)已初步显示出有望成为治疗难治性重度抑郁症患者的速效抗抑郁药,目前正在多项临床试验中进行研究。由于一氧化二氮很少在手术室或牙科诊所之外使用,大多数精神科医生并不熟悉在医疗环境中如何使用一氧化二氮以及指导其使用的规定。本简要综述的目的是让精神科医生了解一氧化二氮给药和药理学的基本概念。此外,还将讨论关于一氧化二氮的常见误解。